| Item type |
デフォルトアイテムタイプ_（フル）(1) |
| 公開日 |
2025-01-30 |
| タイトル |
|
|
タイトル |
Clinical utility of Duke pancreatic monoclonal antigen type 2 in resectable biliary tract cancers |
|
言語 |
en |
| 作成者 |
SUMIYOSHI, Tatsuaki
UEMURA, Kenichirou
SHINTAKUYA, Ryuta
OKADA, Kenjiro
BABA, Kenta
HARADA, Takumi
NAKAMURA, Shinya
MURAKAMI, Yoshiaki
ARIHIRO, Koji
ISHII, Yasutaka
OKA, Shiro
TAKAHASHI, Shinya
|
| アクセス権 |
|
|
アクセス権 |
open access |
|
アクセス権URI |
http://purl.org/coar/access_right/c_abf2 |
| 権利情報 |
|
|
言語 |
en |
|
権利情報 |
Copyright (c) 2024 Hiroshima University Medical Press |
| 主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
biliary tract cancer |
| 主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
duke pancreatic monoclonal antigen type 2 |
| 主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
carbohydrate antigen 19-9 |
| 内容記述 |
|
|
内容記述 |
This study aimed to investigate the clinical utility of Duke pancreatic monoclonal antigen type 2 (DUPAN-2) in addition to carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic Antigen (CEA) in biliary tract cancers (BTCs). Patients who underwent surgery for BTC were investigated. BTCs included five types: intrahepatic cholangiocarcinoma (ICC), hilar cholangiocarcinoma (HC), distal cholangiocarcinoma (DC), gall bladder carcinoma (GBC), and ampullary carcinoma (AC). The percentages of patients with elevated and normal tumor marker levels (high and normal groups) were determined across five BTC types, and recurrence-free survivals (RFSs) were compared between the two groups. Forty, 67, 56, 51, and 51 patients had ICC, HC, DC, GBC, and AC, respectively. In all patients, the percentages of patients with elevated tumor marker levels decreased in the order of CA19-9 (44.9%), DUPAN-2 (36.6%), and CEA (17.0%). This trend was consistent across four cancer types: ICC, HC, DC and GBC. In all patients, the high groups in three markers exhibited significantly poorer RFSs compared to the normal groups (P < 0.01, P < 0.01, P < 0.01, respectively). DUPAN-2 is a useful marker for recurrence in patients with resectable BTC. |
|
言語 |
en |
| 出版者 |
|
|
出版者 |
Hiroshima University Medical Press |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
departmental bulletin paper |
| 出版タイプ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| 開始ページ |
|
|
開始ページ |
35 |
| 書誌情報 |
en : Hiroshima Journal of Medical Sciences
巻 73,
号 3-4,
p. 35-39,
発行日 2024-12
|
| 旧ID |
56194 |
HiroshimaJMedSci_73_35.pdf (1.4 MB)
